» Articles » PMID: 20488778

Bisphenol A Exposure During Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring

Overview
Date 2010 May 22
PMID 20488778
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bisphenol A (BPA) is a widespread endocrine-disrupting chemical used as the base compound in the manufacture of polycarbonate plastics. In humans, epidemiological evidence has associated BPA exposure in adults with higher risk of type 2 diabetes and heart disease.

Objective: We examined the action of environmentally relevant doses of BPA on glucose metabolism in mice during pregnancy and the impact of BPA exposure on these females later in life. We also investigated the consequences of in utero exposure to BPA on metabolic parameters and pancreatic function in offspring.

Methods: Pregnant mice were treated with either vehicle or BPA (10 or 100 microg/kg/day) during days 9-16 of gestation. Glucose metabolism experiments were performed on pregnant mice and their offspring.

Results: BPA exposure aggravated the insulin resistance produced during pregnancy and was associated with decreased glucose tolerance and increased plasma insulin, triglyceride, and leptin concentrations relative to controls. Insulin-stimulated Akt phosphorylation was reduced in skeletal muscle and liver of BPA-treated pregnant mice relative to controls. BPA exposure during gestation had long-term consequences for mothers: 4 months post-partum, treated females weighed more than untreated females and had higher plasma insulin, leptin, triglyceride, and glycerol levels and greater insulin resistance. At 6 months of age, male offspring exposed in utero had reduced glucose tolerance, increased insulin resistance, and altered blood parameters compared with offspring of untreated mothers. The islets of Langerhans from male offspring presented altered Ca2+ signaling and insulin secretion. BrdU (bromodeoxyuridine) incorporation into insulin-producing cells was reduced in the male progeny, yet beta-cell mass was unchanged.

Conclusions: Our findings suggest that BPA may contribute to metabolic disorders relevant to glucose homeostasis and that BPA may be a risk factor for diabetes.

Citing Articles

Impact of Maternal BPA Exposure during Pregnancy on Obesity in Male Offspring: A Mechanistic Mouse Study of Adipose-Derived Exosomal miRNA.

Huang Z, Niu R, Xu Q, Zhang R, Hu W, Qin Y Environ Health Perspect. 2025; 133(1):17011.

PMID: 39886984 PMC: 11783688. DOI: 10.1289/EHP14888.


Global metabolomic alterations associated with endocrine-disrupting chemicals among pregnant individuals and newborns.

Puvvula J, Song L, Zalewska K, Alexander A, Manz K, Braun J Metabolomics. 2025; 21(1):20.

PMID: 39863779 PMC: 11762426. DOI: 10.1007/s11306-024-02219-7.


Environmental Obesogens and Their Perturbations in Lipid Metabolism.

Wang X, Sun Z, Liu Q, Zhou Q, Jiang G Environ Health (Wash). 2024; 2(5):253-268.

PMID: 39474325 PMC: 11504211. DOI: 10.1021/envhealth.3c00202.


Short-Half-Life Chemicals: Maternal Exposure and Offspring Health Consequences-The Case of Synthetic Phenols, Parabens, and Phthalates.

Rousseau-Ralliard D, Bozec J, Ouidir M, Jovanovic N, Gayrard V, Mellouk N Toxics. 2024; 12(10).

PMID: 39453131 PMC: 11511413. DOI: 10.3390/toxics12100710.


The maternal lifestyle in pregnancy: Implications for foetal skeletal muscle development.

Sun H, Chen M, Liao J, He L, Wan B, Yin J J Cachexia Sarcopenia Muscle. 2024; 15(5):1641-1650.

PMID: 39155495 PMC: 11446712. DOI: 10.1002/jcsm.13556.


References
1.
Liu S, Mauvais-Jarvis F . Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology. 2009; 151(3):859-64. PMC: 2840685. DOI: 10.1210/en.2009-1107. View

2.
Kuhl C . Etiology and pathogenesis of gestational diabetes. Diabetes Care. 1998; 21 Suppl 2:B19-26. View

3.
Reece E, Leguizamon G, Wiznitzer A . Gestational diabetes: the need for a common ground. Lancet. 2009; 373(9677):1789-97. DOI: 10.1016/S0140-6736(09)60515-8. View

4.
Wang M, Chen L, Clark G, Lee Y, Stevens R, Ilkayeva O . Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A. 2010; 107(11):4813-9. PMC: 2841945. DOI: 10.1073/pnas.0909422107. View

5.
Sagawa N, Yura S, Itoh H, MISE H, Kakui K, Korita D . Role of leptin in pregnancy--a review. Placenta. 2002; 23 Suppl A:S80-6. DOI: 10.1053/plac.2002.0814. View